News Column

IGI LABORATORIES, INC FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

July 2, 2014

Item 8.01 Other Events.

On July 2, 2014, IGI Laboratories, Inc. (the "Company") announced the closing of the Company's previously announced underwritten public offering of its common stock, including the exercise in full by the underwriters of their over-allotment option to purchase an additional 697,500 shares of common stock. The gross proceeds of the offering, including the exercise of the over-allotment option, were approximately $26.7 million, before deducting underwriting discounts and commissions and offering expenses payable by the Company. A copy of the Company's press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Neither the filing of the press release as an exhibit to this Current Report on Form 8-K nor the inclusion in the press release of a reference to the Company's internet address shall, under any circumstances, be deemed to incorporate the information available at the Company's internet address into this Current Report on Form 8-K. The information available at the Company's internet address is not part of this Current Report on Form 8-K or any other report filed by it with the Securities and Exchange Commission.

Item 9.01 Financial Statements and Exhibits.

(d) The following exhibit is filed with this Report:

Exhibit No. Description 99.1 Press release, dated July 2, 2014, announcing the closing of the public offering

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters